Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin B Leon

Showing results (561-570 of 928) with videos related to

Pageof 93
Sort By:
JACC. Cardiovascular Interventions|June 12, 2024
Predictors and 5-Year Clinical Outcomes of Pacemaker After TAVR: Analysis From the PARTNER 2 SAPIEN 3 RegistriesShmuel Chen, Jose M Dizon, Rebecca T Hahn, et al.
JACC. Cardiovascular Interventions|April 8, 2022
5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical BioprosthesesRebecca T Hahn, John Webb, Philippe Pibarot, et al.
Journal of the American College of Cardiology|May 6, 2017
Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve RegistryJohn G Webb, Michael J Mack, Jonathon M White, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 20, 2008
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trialAlexandra J Lansky, Yoshihiro Tsuchiya, Micheal Brener, et al.
European Heart Journal|July 2, 2025
Carbon emission analysis of aortic valve replacement: the environmental footprint of transcatheter vs. surgical proceduresDavid Blitzer, Christoph J Meinrenken, Nora Bystadhaugen Apelgren, et al.
Journal of the American College of Cardiology|October 22, 2013
Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve)Danny Dvir, Ron Waksman, Israel M Barbash, et al.
JACC. Cardiovascular Interventions|December 9, 2017
Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I TrialSammy Elmariah, William F Fearon, Ignacio Inglessis, et al.
JACC. Cardiovascular Interventions|July 4, 2021
Doppler Velocity Index Outcomes Following Surgical or Transcatheter Aortic Valve Replacement in the PARTNER TrialsRebecca T Hahn, Pamela S Douglas, Wael A Jaber, et al.
The Journal of Invasive Cardiology|October 9, 2012
Gender differences in long-term clinical outcomes after percutaneous coronary intervention of chronic total occlusionsBimmer E Claessen, Alaide Chieffo, George D Dangas, et al.
JAMA Cardiology|March 30, 2022
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive CardiomyopathyMengyao Zhou, Shengjun Ta, Rebecca T Hahn, et al.
Pageof 93

Showing results (561-570 of 928) with videos related to

Sort By:
Pageof 93
JACC. Cardiovascular Interventions|June 12, 2024
Predictors and 5-Year Clinical Outcomes of Pacemaker After TAVR: Analysis From the PARTNER 2 SAPIEN 3 RegistriesShmuel Chen, Jose M Dizon, Rebecca T Hahn, et al.
JACC. Cardiovascular Interventions|April 8, 2022
5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical BioprosthesesRebecca T Hahn, John Webb, Philippe Pibarot, et al.
Journal of the American College of Cardiology|May 6, 2017
Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve RegistryJohn G Webb, Michael J Mack, Jonathon M White, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 20, 2008
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trialAlexandra J Lansky, Yoshihiro Tsuchiya, Micheal Brener, et al.
European Heart Journal|July 2, 2025
Carbon emission analysis of aortic valve replacement: the environmental footprint of transcatheter vs. surgical proceduresDavid Blitzer, Christoph J Meinrenken, Nora Bystadhaugen Apelgren, et al.
Journal of the American College of Cardiology|October 22, 2013
Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve)Danny Dvir, Ron Waksman, Israel M Barbash, et al.
JACC. Cardiovascular Interventions|December 9, 2017
Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I TrialSammy Elmariah, William F Fearon, Ignacio Inglessis, et al.
JACC. Cardiovascular Interventions|July 4, 2021
Doppler Velocity Index Outcomes Following Surgical or Transcatheter Aortic Valve Replacement in the PARTNER TrialsRebecca T Hahn, Pamela S Douglas, Wael A Jaber, et al.
The Journal of Invasive Cardiology|October 9, 2012
Gender differences in long-term clinical outcomes after percutaneous coronary intervention of chronic total occlusionsBimmer E Claessen, Alaide Chieffo, George D Dangas, et al.
JAMA Cardiology|March 30, 2022
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive CardiomyopathyMengyao Zhou, Shengjun Ta, Rebecca T Hahn, et al.
Pageof 93